Business meeting to consider S.4348, to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, S.958, to amend the Public Health Service Act to expand the allowable use criteria for new access points grants for community health centers, and other pending calendar business.